INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/23/2026
Back to search
Official data from USPTO
KISTOSYN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/24/2026
Trademark type
Word
Nice classes
5
Filing date
01/03/2017
Registration date
11/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2025
Last transaction
01/24/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
HU
Examiner
DELANEY, ZHALEH SYBIL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. K. (pessoa física)
Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
Representatives
Engel és Eszes Ügyvédi Iroda
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Aldehydes for pharmaceutical purposes; alginate dietary supplements; aloe vera preparations for pharmaceutical purposes; amino acids for medical purposes; anti-oxidant food supplements; antioxidant enriched coffee for medical purposes; antibiotics; antibiotics for human use; mineral food supplements; food supplements in the nature of anti-oxidants in pill form; mineral waters for medical purposes; asthmatic tea; bacteriological preparations for medical and veterinary use; cultures of microorganisms and biological tissue cultures all for medical and veterinary use; bacterial poisons; bacterial preparations for medical and veterinary use; medicinal diaper rash ointments; medicinal ointments for treating dermatological conditions; balms for medical purposes; gurjun balsam preparations for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases for both medical and veterinary purposes; medicated skin care lotions; skin care creams for medical use; wheat germ dietary supplements; melissa water for pharmaceutical purposes; gallic acid for pharmaceutical purposes; stick liquorice for pharmaceutical purposes; medicinal herbs in the nature of fennel; dietary fiber to aid digestion; dietary fiber for treating constipation; yeast for pharmaceutical purposes; yeast dietary supplements; yeast extracts for pharmaceutical purposes; pharmaceutical preparationselixirs for the treatment of viral and bacterial infections; enzymes for medical purposes; enzyme preparations for medical purposes; cardiotonics; enzyme dietary supplements; expectorants composed of eucalyptol; eucalyptus for pharmaceutical purposes; sterilising preparations; disinfectants; disinfectants and antiseptics; germicides; disinfectants other than disinfectant soap; disinfectants for medical instruments; fumigants; glucose for medical purposes; dietetic by-products of the processing of cereals adapted for medical purposes; glucose dietary supplements; glucose preparations for medical purposes; fungicides; fungicides for medical use; biological fungicides; fungal extracts sold as a component ingredient of nutritional supplements and vitamins; medicinal tea; medicinal drinks; medicinal herbs; medicated candy; extracts of medicinal herbs; herbal teas for medicinal purposes; nutritionally fortified herbal beverages for medical purposes; medicinal herbal extracts for medical purposes; pharmaceutical preparations for the treatment of respiratory diseases; medicated lozenges; sugar-coated medicated lozenges; medicated food supplements; herbal extracts for medical purposes; plant extracts for medical purposes; herbal pills for the treatment of diabetes; natural remedy preparations for the treatment of gastro-intestinal conditionshormonal and chemical imbalancessleep disorders; medicinal herbal preparations; rhubarb roots for pharmaceutical purposes; aloe vera preparations for pharmaceutical purposes; medicinal herbs for smoking cessation; herbal teas for medicinal purposes; urinary tract disinfectants; anti-uric preparations; vaginal washes for medical purposes; douching preparations for medical purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue featuring irish moss; iodine; iodine for pharmaceutical purposes; potassiumsodium and silver iodides for pharmaceutical purposes; camphor oil for medical purposes; camphor for medical purposes; candy for medical purposes; dill oil for medical purposes; capsules sold empty for pharmaceuticals; parasiticides; disposable wipes impregnated with pharmaceutical lotions; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use on plastic and metal surface objects; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use in householdsvehicleshotels and hospitals; pre-moistened medicated wipes; ointments for pharmaceutical purposes; sulfur sticks as disinfectants; flowers of sulfur for pharmaceutical purposes; angostura bark for medical purposes; mangrove bark for pharmaceutical purposes; quebracho bark for medical use; condurango bark for medical purposes; croton bark for medical purposes; collodion for pharmaceutical purposes; extracts of hops for pharmaceutical purposes; air purifying preparations; disinfectant washes for sanitary purposes; sanitary sterilizing preparations in the nature of washes; royal jelly for pharmaceutical purposes; royal jelly dietary supplements; mint for pharmaceutical purposes; menthol for pharmaceutical purposes; mentholated ointment for medical use; mustard poultices for pharmaceutical purposes; medicated body powder composed of mustard; mustard oil for medical purposes; medicinal herb preparations composed of mustard; medicinal roots; myrobalan barks for pharmaceutical purposes; prescription and non-prescription medicinescapsules and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal oils; medicated lozenges for the treatment of respiratory diseases; cough lozenges for medical use; pollen dietary supplements; propolis for pharmaceutical purposes; propolis dietary supplements; chewing gum for medical purposes; medicated bath salts; medicated mouthwash; mouthwashes for medical purposes; gargles for medical purposes; medicated anti-cavity mouth spray; medicated dental rinse; antiseptic mouthwashes; medicated mouthwashesantimicrobial mouthwashes; medicated serums for the treatment of the mouth and throat; syrups for pharmaceutical purposes for the treatment of the mouth for disinfection and for the treatment of respiratory diseases; tinctures of iodine for medical purposes; detergents for medical purposes; vaccines; vitamin tablets; vitamin preparations; vitamin supplements; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; mixed vitamin preparations; gelatin capsules sold empty for pharmaceuticals; fumigation preparations for medical purposes; gurjun balsam for medical purposes; bronchodilating preparations
Publications
History of USPTO decisions and trademark events.
35 publications found
C71T
CANCELLED SECTION 71
05/23/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/08/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/12/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/10/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
02/09/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/06/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/06/2018
PUBO
PUBLISHED FOR OPPOSITION
08/21/2018
GPNX
NOTIFICATION PROCESSED BY IB
08/17/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/01/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/01/2018
NPUB
NOTICE OF PUBLICATION
08/01/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2018
CNEA
EXAMINERS AMENDMENT MAILED
07/16/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
07/14/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/14/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/09/2018
CNFR
FINAL REFUSAL MAILED
01/12/2018
CNFR
FINAL REFUSAL WRITTEN
01/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2017
ALIE
ASSIGNED TO LIE
12/21/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2017
RFNT
REFUSAL PROCESSED BY IB
08/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/20/2017
RFRR
REFUSAL PROCESSED BY MPU
07/20/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/18/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/14/2017
CNRT
NON-FINAL ACTION WRITTEN
07/13/2017
DOCK
ASSIGNED TO EXAMINER
07/12/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/06/2017
Continuous trademark protection
Get notified about every new filing that threatens KISTOSYN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.